Renal Cancer - Results from #4800

Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the HIV-protease inhibitors lopinavir or nelfinavir November 27, 2017

Effects of primary care physician density, urologist presence, and insurance status on stage of diagnosis for urologic malignancies November 24, 2017

Modern Systemic Therapy for Metastatic Renal Cell Carcinoma of the Clear Cell Type November 24, 2017

Identification of Topological Features in Renal Tumor Microenvironment Associated with Patient Survival November 24, 2017

[The analysis of anesthetic management for renal cell carcinoma with associated inferior vena cava tumor thrombus] November 23, 2017

Phosphorylation and Ubiquitination Regulate Protein Phosphatase 5 Activity and Its Prosurvival Role in Kidney Cancer November 23, 2017

Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma November 23, 2017

A review on the management of small renal masses: active surveillance versus surgery November 22, 2017

Growth kinetics and oncologic outcomes for small renal masses managed with active surveillance: a review of the literature November 22, 2017

Surgical Management of Renal Cell Carcinoma Extending Into Venous System: A 20-Year Experience November 22, 2017

High CXC chemokine receptor 1 level represents an independent negative prognosticator in non-metastatic clear-cell renal cell carcinoma patients November 21, 2017

Renal failure during chemotherapy: renal biopsy for assessing subacute nephrotoxicity of pemetrexed November 21, 2017

The pro-apoptosis effect of sinomenine in renal carcinoma via inducing autophagy through inactivating PI3K/AKT/mTOR pathway November 21, 2017

FSCN1 predicts survival and is regulated by a PI3K-dependent mechanism in renal cell carcinoma November 20, 2017

Cure in Advanced Renal Cell Cancer: Is It an Achievable Goal? November 20, 2017

Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial November 20, 2017

Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration November 17, 2017

Genetic polymorphisms in cyclin D1 are associated with risk of renal cell cancer in the Chinese population November 17, 2017

Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer Center November 17, 2017

Adjuvant therapy for locally advanced renal cell carcinoma: A meta-analysis and systematic review November 17, 2017

Page 241 of 456